CymaBay Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
CymaBay Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2011 to Q4 2023.
  • CymaBay Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $10M, a 33.3% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $10M +$2.5M +33.3% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $7.5M -$493K -6.17% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $8M +$792K +11% Dec 31, 2021 10-K 2024-02-28
Q4 2020 $7.21M +$819K +12.8% Dec 31, 2020 10-K 2024-02-28
Q4 2019 $6.39M +$1.8M +39.3% Dec 31, 2019 10-K 2022-03-17
Q4 2018 $4.58M +$1.29M +39.1% Dec 31, 2018 10-K 2021-03-25
Q4 2017 $3.3M +$1.01M +44.1% Dec 31, 2017 10-K 2020-03-16
Q4 2016 $2.29M +$159K +7.48% Dec 31, 2016 10-K 2019-02-28
Q4 2015 $2.13M +$136K +6.83% Dec 31, 2015 10-K 2019-02-28
Q4 2014 $1.99M +$126K +6.76% Dec 31, 2014 10-K 2017-03-23
Q4 2013 $1.87M +$118K +6.75% Dec 31, 2013 10-K 2016-03-29
Q3 2013 $1.75M Sep 30, 2013 10-Q/A 2013-12-16
Q4 2012 $1.75M +$36K +2.1% Dec 31, 2012 10-K 2015-03-23
Q4 2011 $1.71M Dec 31, 2011 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.